Manchester gets offer from United Therapeutics to buy nearly 350 acres in Hacket Hill area [Yahoo! Finance]
United Therapeutics Corporation (UTHR)
Last united therapeutics corporation earnings: 4/29 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.unither.com/investor-relations
Company Research
Source: Yahoo! Finance
The letter, signed by Thomas Kaufman, an associate vice president overseeing corporate real estate, lists the purchase price of the 10 parcels at $4.62 million. City officials contacted by the Union Leader said they were unable to comment on the proposal ahead of next week's meeting of the Board of Mayor and Aldermen scheduled for 7 p.m. on Tuesday at City Hall. Dewey Steadman, head of investor relations for United Therapeutics, said in an email the company has been a "proud part of the Manchester life sciences community since we opened a small office in 2015." Steadman said the company has invested more than $60 million on its Manchester operations and currently employs about 50 people in the city. "We're starting to think about our long-term real estate needs to support our revolutionary work," he said, "and, as such, we're seeking options for a potential future expansion in Manchester to take advantage of the strong, vibrant talent pool that's emerging in the city." Stea
Show less
Read more
Impact Snapshot
Event Time:
UTHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
UTHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
UTHR alerts
High impacting United Therapeutics Corporation news events
Weekly update
A roundup of the hottest topics
UTHR
News
- United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the CHEST 2024 Annual MeetingBusiness Wire
- United Therapeutics Co. (NASDAQ: UTHR) had its price target raised by analysts at Jefferies Financial Group Inc. from $315.00 to $432.00. They now have a "buy" rating on the stock.MarketBeat
- Trans+ employees are not alone in bearing the burden of bigotry—it costs employers, too [Fortune]Fortune
- United Therapeutics Publishes its 2024 Corporate Responsibility and Public Benefit Report Highlighting its Progress Toward a Future Where No Patient Gets Left Behind—EverBusiness Wire
- United Therapeutics Shares Thrive [Yahoo! Finance]Yahoo! Finance
UTHR
Earnings
- 7/31/24 - Miss
UTHR
Sec Filings
- 9/24/24 - Form 4
- 9/23/24 - Form 4
- 9/23/24 - Form 144
- UTHR's page on the SEC website